DCF — CONTRA COSTA REGIONAL MEDICAL CENTER
Enterprise Value: $-526.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-526.2M
Enterprise Value
$-176.0M
PV of Cash Flows
$-350.2M
PV of Terminal Value
$-564.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $612.8M | $-27.6M | -5.0% | $-53.5M | $-48.7M |
| Year 2 | $631.2M | $-22.1M | -4.0% | $-48.8M | $-40.3M |
| Year 3 | $650.1M | $-16.3M | -3.0% | $-43.8M | $-32.9M |
| Year 4 | $669.6M | $-13.4M | -2.0% | $-41.7M | $-28.5M |
| Year 5 | $689.7M | $-12.1M | -2.0% | $-41.3M | $-25.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-526.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$595.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000588279005
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5